gilteritinib-sensitive FLT3 mutants [plasma membrane]

Stable Identifier
R-HSA-9699544
Type
Set [DefinedSet]
Species
Homo sapiens
Compartment
plasma membrane
Locations in the PathwayBrowser
Expand all
Literature References
PubMed ID Title Journal Year
28516360 Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

Ueno, Y, Yamada, M, Kaneko, N, Kuromitsu, S, Mori, M, Saito, R, Shimada, I, Mori, K, Tanaka, R

Invest New Drugs 2017
32040554 Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

Perl, AE, Mori, K, Hill, JE, Tarver, TC, Bahceci, E, Smith, CC, Rahmat, L

Blood Adv 2020
Participants
members
Participates
as a member of
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cite Us!